Close
  Indian J Med Microbiol
 

Figure 5: Change in fasting plasma glucose and postprandial plasma glucose with addition of saxagliptin to ongoing dapagliflozin plus metformin therapy (left panel, Matthaei et al.) and addition of dapagliflozin to ongoing saxagliptin plus metformin therapy (right panel, Mathieu et al.)

Figure 5: Change in fasting plasma glucose and postprandial plasma glucose with addition of saxagliptin to ongoing dapagliflozin plus metformin therapy (left panel, Matthaei <i>et al</i>.) and addition of dapagliflozin to ongoing saxagliptin plus metformin therapy (right panel, Mathieu <i>et al</i>.)